In vitro and in vivo anti-influenza virus activity of diarylheptanoids isolated from Alpinia officinarum

Antiviral Chemistry and Chemotherapy

Volumn 21, Issue 1, 2010, Pages 33-41

  Sawamura, Rie ^a   Shimizu, Tomomi ^a   Sun, Yi ^b   Yasukawa, Ken ^b   Miura, Motofumi ^b   Toriyama, Masaharu ^b   Motohashi, Shigeyasu ^b   Watanabe, Wataru ^a   Konno, Katsuhiko ^a   Kurokawa, Masahiko ^a  

^a KYUSHU UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^b NIHON UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXY 7 (4'' HYDROXYPHENYL) 1 PHENYL 3 HEPTANONE; 7 (4'' HYDROXY 3'' METHOXYPHENYL) 1 PHENYLHEPTEN 3 ONE; AO 0002; AO 0011; HEPTANE DERIVATIVE; MESSENGER RNA; OSELTAMIVIR; RIBAVIRIN; UNCLASSIFIED DRUG; VIRUS RNA;

ALPINIA; ALPINIA OFFICINARUM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ISOLATION; DRUG MECHANISM; FEMALE; INFLUENZA; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL TIME; VIRUS ATTACHMENT; VIRUS TITRATION; WEIGHT REDUCTION;

ALPINIA; ANIMALS; ANTIVIRAL AGENTS; CELL LINE; DIARYLHEPTANOIDS; DOGS; FEMALE; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE; RNA, MESSENGER; RNA, VIRAL; VIRUS ATTACHMENT;

EID: 78751682127     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.3851/IMP1676     Document Type: Article

References (34)

1. Nicholson KG, Aoki FY, Osterhaus AD, et al. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Lancet 2000; 355:1845-1850. (Pubitemid 30311875)
2. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289:179-186. (Pubitemid 36068705)
3. Hayden FG. Amantadine and rimantadine-clinical aspects. In Richman DD (Editor). Antiviral Drug Resistance. Chichester: John Wiley & Sons Ltd Press 1996; pp.59-77.
4. Ison MG, Hayden FG. Therapeutic options for the management of influenza. Curr Opin Pharmacol 2001; 1:482-490.
5. Pitts SR. Use of the neuraminidase inhibitor class of antiviral drugs for treatment of healthy adults with an acute influenza-like illness. Ann Emerg Med 2002; 39:552-554.
6. Englund JA, Champlin RE, Wyde PR, et al. Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults. Clin Infect Dis 1998; 26:1418-1424.
7. McKimm-Breschkin J, Trivedi T, Hampson A, et al. Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir. Antimicrob Agents Chemother 2003; 47:2264-2272. (Pubitemid 36753582)
8. Wetherall NT, Trivedi T, Zeller J, et al. Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network. J Clin Microbiol 2003; 41:742-750. (Pubitemid 36184190)
9. Kurokawa M, Basnet P, Ohsugi M, et al. Anti-herpes simplex virus activity of moronic acid purified from Rhus javanica in vitro and in vivo. J Pharmacol Exp Ther 1999; 289:72-78. (Pubitemid 29156014)
10. Kurokawa M, Hozumi T, Basnet P, et al. Purification and characterization of eugeniin as an anti-herpesvirus compound from Geum japonicum and Syzygium aromaticum. J Pharmacol Exp Ther 1998; 284:728-735. (Pubitemid 28086665)
11. Kurokawa M, Hozumi T, Tsurita M, Kadota S, Nambe T, Shiraki K. Biological characterization of eugeniin as an antiherpes simplex virus type 1 compound in vitro and in vivo. J Pharmacol Exp Ther 2001; 297:372-379. (Pubitemid 32242598)
12. Kurokawa M, Kumeda CA, Yamamura J, Kamiyama T, Shiraki K. Antipyretic activity of cinnamyl derivatives and related compounds in influenza virus-infected mice. Eur J Pharmacol 1998; 348:45-51. (Pubitemid 28266752)
13. Kurokawa M, Tsurita M, Brown J, Fukuda Y, Shiraki K. Effect of interleukin-12 level augmented by Kakkon-to, a herbal medicine, on the early stage of influenza infection in mice. Antiviral Res 2002; 56:183-188.
14. Kurokawa M, Watanabe W, Shimizu T, Sawamura R, Shiraki K. Modulation of cytokine production by 7-hydroxycoumarin in vitro and its efficacy against influenza infection in mice. Antiviral Res 2010; 85:373-380.
15. Lipipun V, Kurokawa M, Suttisri R, et al. Efficacy of Thai medicinal plant extracts against herpes simplex virus type 1 infection in vitro and in vivo. Antiviral Res 2003; 60:175-180.
16. Shimizu T, Hino A, Tsutsumi A, Park YK, Watanabe W, Kurokawa M. Anti-influenza virus activity of propolis in vitro and its efficacy against influenza infection in mice. Antivir Chem Chemother 2008; 19:7-13.
17. Kurokawa M, Ochiai H, Nagasaka K, et al. Antiviral traditional medicines against herpes simplex virus (HSV-1), poliovirus, and measles virus in vitro and their therapeutic efficacies for HSV-1 infection in mice. Antiviral Res 1993; 22:175-188.
18. Ly TN, Shimoyamada M, Kato K, Yamauchi R. Isolation and characterization of some antioxidative compounds from the rhizomes of smaller galanga (Alpinia officinarum Hance). J Agric Food Chem 2003; 51:4924-4929.
19. Ly TN, Shimoyamada M, Kato K, Yamauchi R. Antioxidative compounds isolated from the rhizomes of smaller galanga (Alpinia officinarum Hance). Biofactors 2004; 21:305-308.
20. Lee HJ, Kim JS, Ryu JH. Suppression of inducible nitric oxide synthase expression by diarylheptanoids from Alpinia officinarum. Planta Med 2006; 72:68-71.
21. Kiuchi F, Iwakami S, Shibuya M, Hanaoka F, Sankawa U. Inhibition of prostaglandin and leukotriene biosynthesis by gingerols and diarylheptanoids. Chem Pharm Bull (Tokyo) 1992; 40:387-391.
22. Kiuchi F, Shibuya M, Sankawa U. Inhibitors of prostaglandin biosynthesis from Alpinia officinarum. Chem Pharm Bull (Tokyo) 1982; 30:2279-2282.
23. Sawamura R, Sun Y, Yasukawa K, Shimizu T, Watanabe W, Kurokawa M. Antiviral activities of diarylheptanoids against influenza virus in vitro. J Nat Med 2010; 64:117-120.
24. Kurokawa M, Ochiai H, Nakajima K, Niwayama S. Inhibitory effect of protein kinase C inhibitor on the replication of influenza type A virus. J Gen Virol 1990; 71:2149-2155. (Pubitemid 20296460)
25. Sun Y, Matsubara H, Kitanaka S, Yasukawa K. Diarylheptanoids from the rhizomes of Alpinia officinarum. Helv Chim Acta 2008; 91:118-123.
26. Sun Y, Tabata K, Matsubara H, et al. New cytotoxic diarylheptanoids from the rhizomes of Alpinia officinarum. Planta Med 2008; 74:427-431.
27. World Health Organization. Recommendations and laboratory procedures for detection of avian influenza A(H1N1) virus in specimens from suspected human cases. (Updated August 2007. Accessed October 2007.) Available from http://www.who.int/csr/disease/avian-influenza/guidelines/RecAIlabtestsAug07.pdf
28. Tsurita M, Kurokawa M, Imakita M, Fukuda Y, Watanabe Y, Shiraki K. Early augmentation of interleukin (IL)-12 level in the airway of mice administered orally with clarithromycin or intranasally with IL-12 results in alleviation of influenza infection. J Pharmacol Exp Ther 2001; 298:362-368. (Pubitemid 32574548)
29. Hama Y, Kurokawa M, Imakita M, et al. Interleukin 12 is a primary cytokine responding to influenza virus infection in the respiratory tract of mice. Acta Virol 2009; 53:233-240.
30. Furuta Y, Takahashi K, Fukuda Y, et al. In vitro and in vivo activities of anti-influenza virus compound T-705. Antimicrob Agents Chemother 2002; 46:977-981.
31. Akaike T, Noguchi Y, Ijiri S, et al. Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals. Proc Natl Acad Sci USA 1996; 93:2448-2453.
32. Sato K, Suga M, Akaike T, et al. Therapeutic effect of erythromycin on influenza virus-induced lung injury in mice. Am J Respir Crit Care Med 1998; 157:853-857.
33. Shin D, Kinoshita K, Koyama K, Takahashi K. Antiemetic principles of Alpinia officinarum. J Nat Prod 2002; 65:1315-1318.
34. An N, Xu L-Z, Zou Z-M, Yang S-L. Diarylheptanoids from Alpinia officinarum. J Asian Nat Prod Res 2006; 8:637-641.